RE: Lessons from the selenium and vitamin e cancer prevention trial (SELECT)

Critical Reviews in Biotechnology

Volumn 29, Issue 2, 2009, Pages 81-

  Schrauzer, Gerhard N ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; PLACEBO; SELENIUM; SELENOMETHIONINE; ANTIOXIDANT;

CANCER INCIDENCE; CANCER MORTALITY; CANCER PREVENTION; CANCER RISK; CLINICAL TRIAL; DRUG DISTRIBUTION; DRUG EXCRETION; DRUG TRANSPORT; DRUG UPTAKE; HUMAN; LETTER; PRIORITY JOURNAL; PROSTATE CANCER; RISK REDUCTION; DIET SUPPLEMENTATION; MALE; PROSTATE TUMOR;

ANTIOXIDANTS; CLINICAL TRIALS AS TOPIC; DIETARY SUPPLEMENTS; HUMANS; MALE; PROSTATIC NEOPLASMS; SELENIUM; VITAMIN E;

EID: 70349256096     PISSN: 07388551     EISSN: 15497801     Source Type: Journal    
DOI: 10.1080/07388550902926725     Document Type: Letter

References (4)

1. Lippman SM, Klein EA, Goodman PJ, et al. 2009. Efect of selenium and vitamin E on risk on prostate cancer and other cancers. Te selenium and vitamin E cancer prevention trial (SELECT). JAMA 301(1): 39-51.
2. Schrauzer GN, White DA, Schneider DJ. 1977. Cancer mortality correlation studies. III. Statistical associations with dietary selenium ~ intakes. Bioinorg Chem 7: 23-34.
3. Clark LC, Combs GF, Turnbull BW, Slate EH, Chalker DK, Chow J, Davis LS, Glover RA, Graham GF, Gross EG, Konrad A, Lesher JL, Park HK, Sanders BB, Smith CL, Taylor JR. 1996. Efects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group. JAMA 276: 1957-1963.
4. Bleys J, Navas-Acien A, Guallar E. 2008. Serum selenium levels and all cause, cancer and cardiovascular mortality among US adults. Arch Intern Med 168(4): 404-410.